Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC
Clinical trial NCT05575635 · UNKNOWN
Trial details
- NCT number
- NCT05575635
- Sponsor
- Henan Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2024-05-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.